Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.
Related Posts
Stocks making the biggest moves midday: Pfizer, Palantir, Coinbase, Staar Surgical and more
These are some of the stocks posting the largest midday moves.
Trump slams ‘anti-American’ pushback after fresh delay to Arizona copper mine
Two of the world’s largest mining firms, Rio Tinto and BHP have been trying to develop Resolution Copper for roughly two decades.
Trump officials pitch Zelenskyy on U.S. owning 50% of Ukraine’s rare earth minerals
The Trump administration indicated U.S. troops could be deployed to provide security in connection with the minerals if there’s a peace deal with Russia, sources […]